deepc secures € 12 M funds to expand its AI Platform, partners with LMU

Clinical adoption of artificial intelligence (AI) in medicine is rapidly increasing worldwide. Platforms are giving healthcare systems the flexibility to adopt and integrate third-party AI applications and solutions into existing workflows and ultimately improve patient outcomes.

deepc’s core technology is a cloud-native, vendor-neutral platform that integrates seamlessly with existing radiology workflows. It provides approved third-party AI vendors with an efficient way to commercialize their solutions while offering hospitals and clinics a secure, “one-stop shop” for their AI-assisted radiology needs.

Germany-based AI platform provider deepc has recently raised a € 12 million Series A funding round led by Sofinnova Partners, a venture capital firm in life sciences that specializes in healthcare and sustainability. The new capital will be used to propel the commercialization of the deepcOS AI operating system, and to further develop streamlined services to improve user experience for radiologists. Bertelsmann Investments and existing investor Winning Mindset Ventures also participated in the round.

Partnership at the LMU University Hospital

Munich-based LMU University Hospital has been working on AI solutions for clinical practice and research applications to continuously improve clinical workflows and patient care. For its radiology department, the hospital has entered a close strategic partnership with deepc to systematically apply AI in clinical practice on a broader scale. Through the innovative AI platform, LMU radiologists will gain effortless access to numerous regulatory-cleared AI solutions.

Medical workflows can thus become more efficient, and patient treatment quality can be further increased. Prof. Clemens Cyran, Vice Chair of the Department of Radiology at LMU, is already planning further. “In the future, we would like our colleagues to be alerted in realtime about critical emergency findings that the AI detects in the image data to support prompt patient care,” he said. “We will also focus on the deep integration of various solutions into the existing clinical workflows, such as the automatic transfer of results into report texts or integration with the RIS / PACS, within the framework of work list prioritization.’

“We already have many carefully selected applications from leading AI vendors worldwide fully integrated into our department’s existing IT infrastructure. ”Prof. Clemens Cyran, Vice Chair at the Department of Radiology at LMU

With its two sites, LMU University Hospital Munich is one of the largest hospitals in Europe, treating over 500,000 patients annually. LMU’s radiology department pursues a clearly defined strategy to personalize and optimize diagnostics-guided therapy, which requires using AI in daily practice. LMU radiologists have recently started working on routine diagnostic operations with the deepcOS AI platform developed by the Munichbased medtech company deepc.

“We believe that AI has the power to revolutionize the way we approach healthcare,” said Dr. Franz Pfister, Co-Founder and CEO of deepc. “Our AI platform is a game changer for radiology, allow- ing for faster and more accurate diagnoses, and ultimately improving patient outcomes. We are thrilled to welcome Sofinnova Partners and Bertelsmann Investments on board. Their extensive networks in the healthcare ecosystem will propel deepc forward.”

“ The new capital will enable the company to develop new features and expand commercialization of deepcOS, its proprietary operating system that powers AI integration within radiology workflows.” Julia Moosbauer, COO and Dr. Franz Pfister, CEO of deepc

The new funds will expand deepc’s geographic coverage and help the company develop additional features within its solution. Radiology teams will benefit from new AI-assisted options that are seamlessly integrated into their workflows. At the same time, AI software vendors will get low-friction access to a large number of potential customers, the company wrote in a communiqué.

“Our investment in deepc underscores our conviction that digital medicine holds enormous promise and that enabling technologies will be at the forefront of the digital revolution in healthcare, precisely the focus of our digital medicine investment strategy,” said Simon Turner, Partner at Sofinnova Partners. deepcOS enables wide adoption of AI into a major part of the patient journey. The team has demonstrated the benefit that they can provide to both healthcare professionals and patients.”

https://www.deepc.ai